CrushSCI.com
137.9Average days
124.5Median days
36Fastest days
424Longest days
1,1302025 publications

Paper Review Records

All Paper Review Records

16 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

424 days

Biodegradable radiopaque polymeric particles for computed tomography-guided intraperitoneal drug delivery

Authors
Xenia Kovalyk; Sven Saniternik; Isabell Nies; Markus B. Schütz; Felix Gremse; Larissa M. Hamacher; Anna Rosendahl; Katharina Schwab; Annette M. Schmidt; Nils Große-Hokamp; Holger GrüllShow moreShow less
Affiliations
University of Cologne, Faculty of Medicine and University Hospital Cologne, Institute of Diagnostic and Interventional Radiology, Cologne, 50937, Germany; University of Cologne, Department of Chemistry and Biochemistry, 50939 Cologne, Germany; Core Facility Experimental and Preclinical Imaging Cologne, University of Cologne, Faculty of Medicine and University Hospital Cologne, 50937 Cologne, Germany; Gremse-IT GmbH, 52068 Aachen, GermanyShow moreShow less
Source PDF DOI Publisher page
36 days

A dual-gated engineered bacterial platform for spatiotemporally controlled precise protein degradation

Authors
Shangwu Sun; Ruoxi Hu; Xue Zhai; Rui Bai; Jiaming Guo; Tuoyu Zhou; Tongfu Yang; Qinglan Zeng; Yilin Zhang; Jie Yu; Renke Li; Zuguang Wu; Zhaoting LiShow moreShow less
Affiliations
Meizhou Academy of Medical Sciences, Meizhou People's Hospital (Huangtang Hospital), Meizhou, Guangdong, 514031, PR China; Department of Pharmaceutical Science, Division of Biomedical Health Sciences, School of Medicine, The Chinese University of Hong Kong, Shenzhen, Guangdong, 518172, PR China; Department of Biomedical Sciences, Division of Biomedical Health Sciences, The Chinese University of Hong Kong, Shenzhen, Guangdong, 518172, PR China; Affiliated Longgang Central Hospital of Shantou University Medical College, Longgang Central Hospital of Shenzhen, Shenzhen, 518116, PR China; Toronto General Hospital Research Institute (TGHRI), University Health Network, Toronto, ONM5G 1L7, Canada; Division of Cardiac Surgery, University Health Network, University of Toronto, Toronto, ON, M5G IL7, CanadaShow moreShow less
Source PDF DOI Publisher page
85 days

Decoding extracellular vesicle–biomolecule interactions: How the biomolecular corona shapes extracellular vesicle biodistribution and clearance in vivo

Authors
Xiaoyan Fang; Tianchang He; Hao Fan; Xiaofei Li; Luying Zhou; Wenhua Yang; Lina Zhu; Yuting Ge; Wenshuai Han; Yu Gao; Volker Mailänder; Daniel Crespy; Katharina Landfester; Junfeng Zhang; Shuai JiangShow moreShow less
Affiliations
Key Laboratory of Marine Drugs, Chinese Ministry of Education, School of Medicine and Pharmacy, Ocean University of China, Qingdao, 266003, China; Laboratory for Marine Drugs and Bioproducts, Qingdao Marine Science and Technology Center, Qingdao, 266237, China; Department of Dermatology, University Medical Center of the Johannes Gutenberg-University, Langenbeckstr. 1, Mainz, 55131, Germany; Department of Materials Science and Engineering, School of Molecular Science and Engineering, Vidyasirimedhi Institute of Science and Technology (VISTEC), Rayong, 21210, Thailand; Max Planck Institute for Polymer Research, Ackermannweg 10, Mainz, 55128, GermanyShow moreShow less
Source PDF DOI Publisher page
129 days

Annexin A5-engineered nanovaccines synchronize spatiotemporal antigen release with phagocytosis checkpoint blockade for potent in situ cancer immunotherapy

Authors
Tianjiao Wang; Lu Wang; Xiaoying Kang; Junyan Jiang; Baohui Yuan; Lu Zhang; Xuya Yu; Ting Chen; Xueping Li; Yuan Zhang; Wen Meng; Jian Li; Ji Qi; Dan Ding; Yang Shi; Wen LiShow moreShow less
Affiliations
State Key Laboratory of Advanced Medical Materials and Devices, Tianjin Key Laboratory of Biomedical Materials and Key Laboratory of Biomaterials and Nanotechnology for Cancer Immunotherapy, Institute of Biomedical Engineering, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, Tianjin, 300192, China; State Key Laboratory of Medicinal Chemical Biology, Key Laboratory of Bioactive Materials, Ministry of Education, Frontiers Science Center for Cell Responses, and College of Life Sciences, Nankai University, Tianjin, 300071, ChinaShow moreShow less
Source PDF DOI Publisher page
61 days

Hierarchically sequential targeting nanoplatform suppresses NETosis-promoted angiogenesis for corneal neovascularization therapy

Authors
Chaoqun Wei; Xiaoxue Liu; Yingxuan Bi; Longfei Zhao; Jiahao Shi; Yifei Li; Kejuan Jia; Changlong Wang; Hua GaoShow moreShow less
Affiliations
State Key Laboratory Cultivation Base, Shandong Provincial Key Laboratory of Ophthalmology, Eye Institute of Shandong First Medical University, Qingdao, 266071, China; School of Life Sciences, Shandong First Medical University, Tai'an, 271016, China; Eye Hospital of Shandong First Medical University (Shandong Eye Hospital), Jinan, 250021, China; School of Ophthalmology, Shandong First Medical University, Jinan, 250000, China; Medical Science and Technology Innovation Center, Shandong First Medical University, Jinan, 250117, China; Integrative Center for Frontier Biotech and Pharmaceutical Sciences, Shandong First Medical University, Tai'an, 271016, ChinaShow moreShow less
Source PDF DOI Publisher page
120 days

Sequential lysosome-microtubule targeted transformable nanosystem for long-lasting photodynamic-based multimodal therapy of breast cancer

Authors
Ruyi Lin; Li Xia; Yatong Zhang; Jia Yan; Yujun Song; Yufan Du; Yuan Huang; Jing Wang; Hao Wang; Huile Gao; Fan TongShow moreShow less
Affiliations
Key Laboratory of Drug-Targeting and Drug Delivery System of the Education Ministry, Sichuan Engineering Laboratory for Plant-Sourced Drug and Sichuan Research Center for Drug Precision Industrial Technology, West China School of Pharmacy, Sichuan University, Chengdu 610064, PR China; Department of Breast, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, University of Electronic Science and Technology of China, Chengdu, PR China; School of Pharmacy, National Key Laboratory of New Pharmaceutical Preparations and Excipients, Hebei Medical University, Shijiazhuang 050017, PR ChinaShow moreShow less
Source PDF DOI Publisher page

FAQ

How long does JOURNAL OF CONTROLLED RELEASE take to review a manuscript?

As of 2026-11-19, CrushSCI has 16 complete review records for JOURNAL OF CONTROLLED RELEASE. The fastest paper went from submission to acceptance in 36 days (A dual-gated engineered bacterial platform for spatiotemporally controlled precise protein degradation, received 2026-09-08, accepted 2026-10-14); the slowest took 424 days. The average is 137.9 days and the median is 124.5 days.

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

We will reply within 30 minutes.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review59.6 days

Median65 days

Contact CrushSCI

Contact CrushSCI

Leave your email address to discuss academic polishing, structural refinement, or one-to-one guidance.

We will reply within 30 minutes.

Selected service: Academic Consulting Service

Leave your email address

Or email us directly at leader@crushsci.com

Enter your email address so we can reply. Your details will remain private.